naturalX Health Ventures advises on a €100 million investment in Function Health during a $298 million Series B funding round, valuing the company at $2.5 billion.
Target Information
Function Health is pioneering a groundbreaking preventive health model aimed at consumers, designed to enhance personal health management through innovative technology. Central to its offerings is a comprehensive panel of over 160 biomarkers that provide users with valuable insights into their metabolic, hormonal, cardiovascular, and immunological health. This proactive approach enables early detection of health risks that might otherwise go unnoticed, empowering individuals to take charge of their health.
Building on its initial success, Function Health has unveiled its 'Medical Intelligence Lab', which leverages artificial intelligence to integrate laboratory results, imaging, wearable devices, medical records, and global research into a dynamic and personalized health model. This advanced system continuously learns and identifies patterns, translating them into actionable health recommendations tailored for each user.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
Function Health operates within the thriving consumer health industry, which has seen significant growth as individuals increasingly prioritize preventive health solutions. The industry is evolving rapidly, driven by advancements in technolog
Similar Deals
naturalX Health Ventures
invested in
Function Health
in 2025
in a Series B deal
Disclosed details
Transaction Size: $298M
Enterprise Value: $2,500M
Equity Value: $2,500M